Evidence map›Paper›PMID 22235289›Full record

ArticlePloS one2012

Statistical properties and robustness of biological controller-target networks.

Jacob D Feala, Jorge Cortes, Phillip M Duxbury, Andrew D McCulloch, Carlo Piermarocchi, Giovanni Paternostro

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension.International journal of molecular sciences · 2018
    Review
  2. Article
  3. Article
  4. Article
  5. A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia.Journal of computational biology : a journal of computational molecular cell biology · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jacob D FealaSanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Jorge Cortes
Phillip M Duxbury
Andrew D McCulloch
Carlo Piermarocchi
Giovanni Paternostro

Funding

VISUALIZATION TOOLS FOR AUTOMATED MOLECULAR MICROSCOPYP41RR008605 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PAPADOPOULOS, PHILIP · 1994 to 2011
$28.1M
Systems Biology CoreP01HL098053 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POWELL, FRANK L. · 2010 to 2014
$10.2M
Molecular Algorithmics for Pharmacological InterventionsR21AG030685 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PATERNOSTRO, GIOVANNI · 2009 to 2010
$431k
NCRR NIH HHS P41 RR008605NCRR NIH HHS P41-RR08605NHLBI NIH HHS P01 HL098053NHLBI NIH HHS P01-HL098053NIA NIH HHS R21 AG030685NIA NIH HHS R21AG030685
6 · The paper itself

Abstract

Cells are regulated by networks of controllers having many targets, and targets affected by many controllers, in a "many-to-many" control structure. Here we study several of these bipartite (two-layer) networks. We analyze both naturally occurring biological networks (composed of transcription factors controlling genes, microRNAs controlling mRNA transcripts, and protein kinases controlling protein substrates) and a drug-target network composed of kinase inhibitors and of their kinase targets. Certain statistical properties of these biological bipartite structures seem universal across systems and species, suggesting the existence of common control strategies in biology. The number of controllers is ∼8% of targets and the density of links is 2.5%±1.2%. Links per node are predominantly exponentially distributed. We explain the conservation of the mean number of incoming links per target using a mathematical model of control networks, which also indicates that the "many-to-many" structure of biological control has properties of efficient robustness. The drug-target network has many statistical properties similar to the biological networks and we show that drug-target networks with biomimetic features can be obtained. These findings suggest a completely new approach to pharmacological control of biological systems. Molecular tools, such as kinase inhibitors, are now available to test if therapeutic combinations may benefit from being designed with biomimetic properties, such as "many-to-many" targeting, very wide coverage of the target set, and redundancy of incoming links per target.

Indexed as

BiometryBiomimeticsDrug DesignGene Regulatory NetworksHumansMicroRNAsProtein KinasesRNA, MessengerTranscription FactorsMicroRNAsProtein KinasesRNA, MessengerTranscription Factors

Identifiers

PMID22235289
PMCPMC3250441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.